PharmaShots | Incisive News in 3 Shots

Subscribe Now

MACE

Eli Lilly's Trulicity (dulaglutide) Receives the US FDA's Approval to Reduce MACE in T2D Adults

Eli Lilly's Trulicity (dulaglutide) Receives the US FDA's Approval to Reduce MACE in T2D Adults

February 24, 2020

Novo Nordisk's Ozempic (semaglutide) Receives the US FDA's Approval for Reduction in MACE in Patients with Type 2 Diabetes

Novo Nordisk's Ozempic (semaglutide) Receives the US FDA's Approval for Reduction in MACE in Patients with Type 2 Diabetes

January 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us